Life Sciences Advanced Technologies

Executive Summary

Life Sciences Advanced Technologies (LSAT) is a privately held diagnostics and medical devices company headquartered in St. Petersburg, Florida. Founded in 1990, the company has a long-standing presence in the life sciences sector, focusing on providing superior products and services to support scientific research. LSAT's mission emphasizes saving lives and futures by enabling researchers with advanced tools and technologies. While the company operates in the competitive diagnostics and medical devices space, its specific product portfolio and market positioning remain relatively undisclosed, limiting visibility into its current commercial traction. The company appears to target a niche within the research community, potentially offering specialized assay kits, laboratory equipment, or point-of-care devices.

Upcoming Catalysts (preview)

• Q3 2026Launch of a novel diagnostic platform for infectious disease detection30% success
• Q1 2027FDA 510(k) clearance for a new medical device25% success
• Q4 2026Strategic partnership with a major research institution or distributor20% success